Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Director Juan R. Luciano acquired 25 shares of Eli Lilly common stock through a deferral plan, with settlement occurring after separation from service.

Summary

• Juan R. Luciano, a director at Eli Lilly & Co, acquired 25 shares of common stock on December 18, 2023.
• The shares were acquired at a price of $579.76 per share.
• This acquisition was made through the Lilly Directors' Deferral Plan, where the shares are deferred in lieu of cash compensation.
• The shares will be settled in common stock after Mr. Luciano's separation from service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is a routine event and can be seen as a sign of confidence in the company, but it is not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine transaction for a director of a public company, often part of their compensation package. It reflects standard practice in corporate governance and executive compensation.

Comparison to Industry Standards

• Director share acquisitions through deferral plans are common among large public companies like Eli Lilly.
• These plans are often used to align the interests of directors with those of shareholders, encouraging long-term value creation.
• Similar practices can be observed at companies like Pfizer (PFE) and Johnson & Johnson (JNJ), where directors often receive stock-based compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Units, LLY